This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-02-09 CDAMG Conference Call"

From HL7Wiki
Jump to navigation Jump to search
Line 91: Line 91:
 
****Expectation for CDA R2.0 after CDA R2.1 is released?
 
****Expectation for CDA R2.0 after CDA R2.1 is released?
 
****What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
 
****What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
 +
****Strategies for aligning C-CDA with FHIR?
 
**Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
 
**Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
 
***Review minutes from 2018-01-29.
 
***Review minutes from 2018-01-29.
 
***Is our plan sufficiently clear and actionable?  Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
 
***Is our plan sufficiently clear and actionable?  Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
 
**Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
 
**Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
 +
**Discuss C-CDA Value Set Maintenance situation - what role needed from CMG? (Lisa)
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===

Revision as of 14:49, 9 February 2018

back to CDA Management Group main page

HL7 CDAMG Minutes

Location: Pelican - Riverside Bldg.

Date: 2018-02-09
Time: 2:00 PM (ET)
Facilitator Brett Note taker(s) Lisa
Attendee Name


George Dixon
Jean Duteau
Rick Geimer
Kai Heitmann
Brett Marquard
Linda Michaelsen
Dale Nelson
Lisa Nelson
Andrew Statler
Quorum: Chair +3

Agenda & Minutes

  • Welcome
  • Agenda review
  • Approve Minutes of 2018-01-29_CDAMG_WGM
  • Review items
  • Discussion Topics
    • SWOT
      • Reviewed the SWOT
      • Any updates as a result of activity at the WGM?
      • Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
    • Asset List - Status, and ongoing management.
      • Discuss Status/Development toward CDA Template Interchage Format
      • Discuss Status of CDA Template Registry
      • What actions remain to be completed?
        • Review progress on CMG Wiki changes - what's left to be completed?
    • Discuss need for & Development of overall CDA Product Roadmap
      • Roadmap needs to address questions like:
        • Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
        • Expectation for CDA R2.0 after CDA R2.1 is released?
        • What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
        • Strategies for aligning C-CDA with FHIR?
    • Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
      • Review minutes from 2018-01-29.
      • Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
    • Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
    • Discuss C-CDA Value Set Maintenance situation - what role needed from CMG? (Lisa)

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved